Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Robert Desantis sold 376 shares of the company's stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $375.39, for a total value of $141,146.64. Following the transaction, the executive vice president now directly owns 5,507 shares of the company's stock, valued at approximately $2,067,272.73. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Robert Desantis also recently made the following trade(s):
- On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The stock was sold at an average price of $369.92, for a total value of $554,140.16.
- On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.16, for a total value of $128,362.64.
- On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total value of $7,992,564.80.
Intuitive Surgical Price Performance
Warren Buffett's "mystery stock"
From Stansberry Research | Ad
WARNING: Read This Before the Next Fed Meeting
Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.
This Wall Street millionaire just stepped forward with all the details, and how it could make some
ISRG stock opened at $370.62 on Wednesday. The company has a market cap of $131.46 billion, a P/E ratio of 66.90, a price-to-earnings-growth ratio of 4.85 and a beta of 1.36. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock's fifty day moving average price is $385.96 and its 200-day moving average price is $348.19.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.10. The firm had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company's revenue for the quarter was up 11.5% on a year-over-year basis. During the same period last year, the business posted $1.00 EPS. As a group, analysts expect that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current year.
Hedge Funds Weigh In On Intuitive Surgical
A number of institutional investors have recently bought and sold shares of ISRG. Brookstone Capital Management raised its holdings in Intuitive Surgical by 277.7% in the 3rd quarter. Brookstone Capital Management now owns 7,259 shares of the medical equipment provider's stock worth $1,985,000 after purchasing an additional 5,337 shares during the period. Commonwealth Equity Services LLC raised its holdings in Intuitive Surgical by 10.9% in the 3rd quarter. Commonwealth Equity Services LLC now owns 61,148 shares of the medical equipment provider's stock worth $17,873,000 after purchasing an additional 6,018 shares during the period. RMR Wealth Builders raised its holdings in Intuitive Surgical by 66.5% in the 3rd quarter. RMR Wealth Builders now owns 4,076 shares of the medical equipment provider's stock worth $1,191,000 after purchasing an additional 1,628 shares during the period. Accurate Wealth Management LLC raised its holdings in Intuitive Surgical by 4.1% in the 3rd quarter. Accurate Wealth Management LLC now owns 5,094 shares of the medical equipment provider's stock worth $1,403,000 after purchasing an additional 199 shares during the period. Finally, Balboa Wealth Partners raised its holdings in Intuitive Surgical by 3.3% in the 3rd quarter. Balboa Wealth Partners now owns 5,619 shares of the medical equipment provider's stock worth $1,642,000 after purchasing an additional 180 shares during the period. 83.64% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
ISRG has been the topic of several recent research reports. Truist Financial upped their price target on Intuitive Surgical from $390.00 to $435.00 and gave the stock a "buy" rating in a research note on Wednesday, January 24th. BTIG Research upped their price target on Intuitive Surgical from $412.00 to $421.00 and gave the stock a "buy" rating in a research note on Friday, April 19th. StockNews.com downgraded Intuitive Surgical from a "buy" rating to a "hold" rating in a research note on Thursday, February 29th. Piper Sandler upped their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an "overweight" rating in a research note on Friday, April 19th. Finally, Barclays upped their price target on Intuitive Surgical from $385.00 to $430.00 and gave the stock an "overweight" rating in a research note on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $396.17.
Check Out Our Latest Report on ISRG
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
